Companies, Hospitals Line Up As FDA Device Center Training Sites
This article was originally published in The Gray Sheet
More than 30 medical device-makers and clinical sites extended onsite invites to CDRH staffers to learn more about a wide array of industry topics, including neurointerventional device issues, male condom manufacturing, product reprocessing and sterilization methods.
You may also be interested in...
CDRH is asking for another round of volunteers to allow officials to visit manufacturing and clinical facilities to get first-hand perspective of how they operate as part of the center's Experimental Learning Program.
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.